These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 17357565)

  • 61. Refined structures of three crystal forms of toxic shock syndrome toxin-1 and of a tetramutant with reduced activity.
    Prasad GS; Radhakrishnan R; Mitchell DT; Earhart CA; Dinges MM; Cook WJ; Schlievert PM; Ohlendorf DH
    Protein Sci; 1997 Jun; 6(6):1220-7. PubMed ID: 9194182
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Detection of circulating bacterial superantigen and lymphotoxin-alpha in patients with streptococcal toxic-shock syndrome.
    Sriskandan S; Moyes D; Cohen J
    Lancet; 1996 Nov; 348(9037):1315-6. PubMed ID: 8909404
    [No Abstract]   [Full Text] [Related]  

  • 63. Cellular and molecular mechanisms of immune activation by microbial superantigens: studies using toxic shock syndrome toxin-1.
    Chatila T; Scholl P; Ramesh N; Trede N; Fuleihan R; Morio T; Geha RS
    Chem Immunol; 1992; 55():146-71. PubMed ID: 1418616
    [No Abstract]   [Full Text] [Related]  

  • 64. Stimulation of rat spleen cells by staphylococcal enterotoxins.
    Holbrook MR; Young KE; Gibbon LG; Webster CA; Tranter HS; Arbuthnott JP; Todd I
    FEMS Immunol Med Microbiol; 1993 Aug; 7(2):169-74. PubMed ID: 8401429
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Toxic shock syndrome toxin-1 (TSST-1) antibody levels in Japanese children.
    Quan L; Morita R; Kawakami S
    Burns; 2010 Aug; 36(5):716-21. PubMed ID: 20036064
    [TBL] [Abstract][Full Text] [Related]  

  • 66. In vivo and in vitro detection of a superantigenic toxin Vbeta signature in two forms of streptococcal toxic shock syndrome.
    Thomas D; Perpoint T; Dauwalder O; Lina G; Floccard B; Richard JC; Bouvet A; Peyramond D; Allaouchiche B; Chidiac C; Vandenesch F; Etienne J; Ferry T
    Eur J Clin Microbiol Infect Dis; 2009 Jun; 28(6):671-6. PubMed ID: 19020908
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Adult chickenpox complicated by fatal necrotising pneumonia.
    Stride PJ; Campher MJ; Geary JM; Coulter C; Duhig EE
    Med J Aust; 2004 Aug; 181(3):160-1. PubMed ID: 15287836
    [No Abstract]   [Full Text] [Related]  

  • 68. Staphylococcal toxic shock syndrome, superantigenicity, and hypersensitivity.
    Landman GW; Groeneveld PH
    Clin Infect Dis; 2010 May; 50(9):1326; author reply 1326-7. PubMed ID: 20367234
    [No Abstract]   [Full Text] [Related]  

  • 69. Comparative inflammatory properties of staphylococcal superantigenic enterotoxins SEA and SEG: implications for septic shock.
    Dauwalder O; Thomas D; Ferry T; Debard AL; Badiou C; Vandenesch F; Etienne J; Lina G; Monneret G
    J Leukoc Biol; 2006 Oct; 80(4):753-8. PubMed ID: 16885504
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis.
    Parks T; Wilson C; Curtis N; Norrby-Teglund A; Sriskandan S
    Clin Infect Dis; 2018 Oct; 67(9):1434-1436. PubMed ID: 29788397
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Efficacy of polyspecific intravenous immunoglobulin therapy in streptococcal toxic shock syndrome.
    Arends JE; Harkisoen S
    Clin Infect Dis; 2015 Jan; 60(2):324. PubMed ID: 25313253
    [No Abstract]   [Full Text] [Related]  

  • 72. Superantigen and endotoxin synergize in the induction of lethal shock.
    Blank C; Luz A; Bendigs S; Erdmann A; Wagner H; Heeg K
    Eur J Immunol; 1997 Apr; 27(4):825-33. PubMed ID: 9130631
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Production of human and murine interleukin-2 by toxic shock syndrome toxin-1.
    Micusan VV; Mercier G; Bhatti AR; Reiser RF; Bergdoll MS; Oth D
    Immunology; 1986 Jun; 58(2):203-8. PubMed ID: 3486824
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Necrotizing fasciitis.
    Cherneski CL; Embil JM
    Saudi Med J; 2001 Jul; 22(7):565-8. PubMed ID: 11479634
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Staphylococcal and streptococcal superantigens: molecular, biological and clinical aspects.
    Alouf JE; Müller-Alouf H
    Int J Med Microbiol; 2003 Feb; 292(7-8):429-40. PubMed ID: 12635926
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Streptococcal toxic shock associated with septic abortion.
    Dotters DJ; Katz VL
    Obstet Gynecol; 1991 Sep; 78(3 Pt 2):549-51. PubMed ID: 1870820
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Fatal group A Streptococcal toxic shock-like syndrome in a child with varicella: report of the first well documented case with detection of the genetic sequences that code for exotoxins spe A and B, in São Paulo, Brazil.
    Sztajnbok J; Lovgren M; Brandileone MC; Marotto PC; Talbot JA; Seguro AC
    Rev Inst Med Trop Sao Paulo; 1999; 41(1):63-5. PubMed ID: 10436672
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Individual genetic variations directly effect polarization of cytokine responses to superantigens associated with streptococcal sepsis: implications for customized patient care.
    Nooh MM; Nookala S; Kansal R; Kotb M
    J Immunol; 2011 Mar; 186(5):3156-63. PubMed ID: 21282506
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gram-positive bacterial superantigen outside-in signaling causes toxic shock syndrome.
    Brosnahan AJ; Schlievert PM
    FEBS J; 2011 Dec; 278(23):4649-67. PubMed ID: 21535475
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hemoadsorption therapy for sepsis syndromes.
    Kellum JA
    Crit Care Med; 2003 Jan; 31(1):323-4. PubMed ID: 12545045
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.